HEERLEN, NETHERLANDS--(Marketwired - May 3, 2013) -
The DSM Annual General Meeting of Shareholders on 3 May 2013 passed a
resolution to declare a dividend for 2012 of EUR1.50 per ordinary share of
EUR1.50 par value. An interim dividend of EUR0.48 per ordinary share having
been paid on 30 August 2012, the final dividend for 2012 will amount to
EUR1.02 per ordinary share. With the passing of the resolution by the AGM,
and in line with DSM's policy to provide a stable and preferably rising
dividend, 2012 marks the third consecutive year DSM's dividend has been
increased.
This final dividend of EUR1.02 will be paid out in cash or in the form of ordinary shares at the option of the shareholder. Dividend in cash will be paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on NYSE Euronext will be 7 May 2013 and the record date will be 9 May 2013.
Shareholders have from 10 May until 24 May 2013 (3.00 pm CET) to indicate their choice. On 27 May 2013 after the close of trading on NYSE Euronext the number of dividend rights of ordinary shares entitling the holder to one ordinary share will be determined.
This exchange ratio will be based on the volume weighted average price of all ordinary shares in DSM traded at NYSE Euronext on 20 May 2013 up to and including 24 May 2013. The value of the stock dividend will be virtually equal to the value of the cash dividend. The ordinary shares that constitute the stock dividend are entitled to any dividend for the financial year 2013 and to the dividends for subsequent financial years. Stock dividend rights will not be traded on NYSE Euronext.
The following timetable applies:
7 May 2013: Ex-dividend quotation
9 May 2013: Record Date
10 May 2013 - 24 May 2013(3.00 pm CET): Period in which shareholders can
indicate their choice
27 May 2013 (COB): Announcement of the exchange ratio
29 May 2013: Delivery of shares or cash payment
DSM - Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio- based materials. DSM's 23,500 employees deliver annual net sales of around EUR9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com .
Press release-pdf:
http://hugin.info/130663/R/1699045/560335.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1699045]
For more information: DSM Corporate Communications Herman Betten tel. +31 (0) 45 5782017 e-mail Email Contact DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 e-mail Email Contact
